keyword
https://read.qxmd.com/read/38627138/kidney-transplantation-during-covid-19-outbreak-data-from-public-and-non-public-dialysis-network
#21
JOURNAL ARTICLE
Jacek Zawierucha, Wojciech Marcinkowski, Jacek Małyszko, Jolanta Małyszko
BACKGROUND: The COVID-19 pandemic significantly affected medical services in Poland. All restrictions, additional procedures, and numerous infections among medical staff affected transplantation in the country. This study aimed to analyze reports prepared by the Polish Transplant Coordination Center Poltransplant and internal Fresenius Nephrocare Poland to assess differences in the number of patients who qualified for kidney transplantation and transplanted during the pandemic compared with a pre-pandemic year...
April 15, 2024: Transplantation Proceedings
https://read.qxmd.com/read/38626496/associations-between-heat-waves-and-chronic-kidney-disease-in-china-the-modifying-role-of-land-cover
#22
JOURNAL ARTICLE
Wanzhou Wang, Fulin Wang, Chao Yang, Jinwei Wang, Ze Liang, Feifei Zhang, Pengfei Li, Luxia Zhang
The increasing frequency of heat waves under the global urbanization and climate change background poses elevating risks of chronic kidney disease (CKD). Nevertheless, there has been no evidence on associations between long-term exposures to heat waves and CKD as well as the modifying effects of land cover patterns. Based on a national representative population-based survey on CKD covering 47,086 adults and high spatial resolution datasets on temperature and land cover data, we found that annual days of exposure to heat waves were associated with increased odds of CKD prevalence...
April 12, 2024: Environment International
https://read.qxmd.com/read/38626061/association-between-dyslipidemia-and-the-risk-of-incident-chronic-kidney-disease-affected-by-genetic-susceptibility-polygenic-risk-score-analysis
#23
JOURNAL ARTICLE
Boram Weon, Yunjeong Jang, Jinyeon Jo, Wencheng Jin, Seounguk Ha, Ara Ko, Yun Kyu Oh, Chun Soo Lim, Jung Pyo Lee, Sungho Won, Jeonghwan Lee
BACKGROUND: The effect of dyslipidemia on kidney disease outcomes has been inconclusive, and it requires further clarification. Therefore, we aimed to investigate the effects of genetic factors on the association between dyslipidemia and the risk of chronic kidney disease (CKD) using polygenic risk score (PRS). METHODS: We analyzed data from 373,523 participants from the UK Biobank aged 40-69 years with no history of CKD. Baseline data included plasma levels of total cholesterol, low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), and triglyceride, as well as genome-wide genotype data for PRS...
2024: PloS One
https://read.qxmd.com/read/38626029/common-questions-and-misconceptions-about-protein-supplementation-what-does-the-scientific-evidence-really-show
#24
REVIEW
Jose Antonio, Cassandra Evans, Arny A Ferrando, Jeffrey R Stout, Brandi Antonio, Harry Cinteo, Patrick Harty, Shawn M Arent, Darren G Candow, Scott C Forbes, Chad M Kerksick, Flavia Pereira, Drew Gonzalez, Richard B Kreider
Protein supplementation often refers to increasing the intake of this particular macronutrient through dietary supplements in the form of powders, ready-to-drink shakes, and bars. The primary purpose of protein supplementation is to augment dietary protein intake, aiding individuals in meeting their protein requirements, especially when it may be challenging to do so through regular food (i.e. chicken, beef, fish, pork, etc.) sources alone. A large body of evidence shows that protein has an important role in exercising and sedentary individuals...
December 2024: Journal of the International Society of Sports Nutrition
https://read.qxmd.com/read/38625648/association-between-atherogenic-indexes-and-erectile-dysfunction-a-cross-sectional-analysis-of-the-national-health-and-nutrition-examination-survey-2001-2004
#25
JOURNAL ARTICLE
Lange Guo, Yukui Nan, Lizhong Yao
PURPOSE: Elevated blood lipids are considered a risk factor for atherosclerosis, which can lead to erectile dysfunction. This study aimed to explore the relationship between the atherogenic index of plasma (AIP), atherogenic coefficient (AC), Castelli's risk index-I (CRI-I), Castelli's risk index-II (CRI-II), and erectile dysfunction. METHODS: Based on the National Health and Nutrition Examination Survey (NHANES) data from 2001-2004, multivariable-adjusted logistic regression models were used to evaluate the association between AIP, AC, CRI-I, and CRI-II with ED...
April 16, 2024: International Urology and Nephrology
https://read.qxmd.com/read/38625480/design-cohort-profile-and-comparison-of-the-ktd-innov-study-a-prospective-multidimensional-biomarker-validation-study-in-kidney-allograft-rejection
#26
JOURNAL ARTICLE
Valentin Goutaudier, Marta Sablik, Maud Racapé, Olivia Rousseau, Benoit Audry, Nassim Kamar, Marc Raynaud, Olivier Aubert, Béatrice Charreau, Emmanuelle Papuchon, Richard Danger, Laurence Letertre, Lionel Couzi, Emmanuel Morelon, Moglie Le Quintrec, Jean-Luc Taupin, Eric Vicaut, Christophe Legendre, Hoa Le Mai, Vishnu Potluri, Thi-Van-Ha Nguyen, Marie-Eliane Azoury, Alice Pinheiro, Georges Nouadje, Pierre Sonigo, Dany Anglicheau, Ineke Tieken, Serge Vogelaar, Christian Jacquelinet, Peter Reese, Pierre-Antoine Gourraud, Sophie Brouard, Carmen Lefaucheur, Alexandre Loupy
There is an unmet need for robust and clinically validated biomarkers of kidney allograft rejection. Here we present the KTD-Innov study (ClinicalTrials.gov, NCT03582436), an unselected deeply phenotyped cohort of kidney transplant recipients with a holistic approach to validate the clinical utility of precision diagnostic biomarkers. In 2018-2019, we prospectively enrolled consecutive adult patients who received a kidney allograft at seven French centers and followed them for a year. We performed multimodal phenotyping at follow-up visits, by collecting clinical, biological, immunological, and histological parameters, and analyzing a panel of 147 blood, urinary and kidney tissue biomarkers...
April 16, 2024: European Journal of Epidemiology
https://read.qxmd.com/read/38625385/renal-manifestations-in-adult-onset-still-s-disease-a-systematic-review
#27
P V Akhila Arya, Erica Marnet, Madhumita Rondla, Jia Wei Tan, Dileep Unnikrishnan, Gregory Buller
OBJECTIVE: We aimed to review the literature on the clinical presentation, renal pathology, treatment, and outcome of renal manifestations in adult-onset Still's disease (AOSD). METHODS: We used PRISMA guidelines for our systematic review and included all English-language original articles from inception till September 15, 2023, on AOSD and kidney involvement in any form. Data on patient demographics, diagnostic criteria, clinical presentation, renal pathology, treatment employed including dialysis, outcome, cause of death were collected and analyzed...
April 16, 2024: Rheumatology International
https://read.qxmd.com/read/38621950/-status-of-outcome-measures-in-randomized-controlled-trials-of-kidney-tonifying-and-blood-activating-method-in-treatment-of-knee-osteoarthritis
#28
JOURNAL ARTICLE
Ji-Xin Chen, Qin-Xin Zhou, Wei-Jie Yu, Tian-Ci Guo, Pu-Yu Niu, Yun-Tian Ye, Ai-Feng Liu
This study assesses the status of outcome measures in the randomized controlled trial(RCT) involving the kidney-tonif-ying and blood-activating method for treating knee osteoarthritis(KOA), aiming to establish a theoretical foundation for the development of a core set of outcome measures in traditional Chinese medicine(TCM) treatment of KOA. The relevant articles were retrieved from CNKI, Wanfang, VIP, SinoMed, PubMed, EMbase, Cochrane Library, and Web of Science, in addition to ClinicalTrials.gov and the China Clinical Trial Registration Center, with the time interval from inception to August 2023...
March 2024: Zhongguo Zhong Yao za Zhi, Zhongguo Zhongyao Zazhi, China Journal of Chinese Materia Medica
https://read.qxmd.com/read/38621240/nephrology-what-you-may-have-missed-in-2023
#29
JOURNAL ARTICLE
Ali A M AlHabobi, Ashwaq M S Almutairi, Danah A S Y Bohemid, Ashwini R Sehgal
This article highlights a selection of important nephrology studies published in 2023 that have relevance for nonnephrologist physicians. Four studies examined progression of chronic kidney disease or cardiovascular disease with respect to finerenone use, magnesium supplementation, iron markers, and COVID-19. Two studies examined treatments to improve specific aspects of chronic kidney disease management, including daprodustat to address anemia and patiromer to address hyperphosphatemia. One study showed that acetazolamide added to loop diuretics increased diuresis in acute decompensated heart failure across a wide range of renal function...
April 16, 2024: Annals of Internal Medicine
https://read.qxmd.com/read/38619824/electronic-health-record-population-health-management-for-chronic-kidney-disease-care-a-cluster-randomized-clinical-trial
#30
JOURNAL ARTICLE
Manisha Jhamb, Melanie R Weltman, Susan M Devaraj, Linda-Marie Ustaris Lavenburg, Zhuoheng Han, Alaa A Alghwiri, Gary S Fischer, Bruce L Rollman, Thomas D Nolin, Jonathan G Yabes
IMPORTANCE: Large gaps in clinical care in patients with chronic kidney disease (CKD) lead to poor outcomes. OBJECTIVE: To compare the effectiveness of an electronic health record-based population health management intervention vs usual care for reducing CKD progression and improving evidence-based care in high-risk CKD. DESIGN, SETTING, AND PARTICIPANTS: The Kidney Coordinated Health Management Partnership (Kidney CHAMP) was a pragmatic cluster randomized clinical trial conducted between May 2019 and July 2022 in 101 primary care practices in Western Pennsylvania...
April 15, 2024: JAMA Internal Medicine
https://read.qxmd.com/read/38619822/sodium-glucose-cotransporter-2-inhibitors-vs-sulfonylureas-for-gout-prevention-among-patients-with-type-2-diabetes-receiving-metformin
#31
JOURNAL ARTICLE
Natalie McCormick, Chio Yokose, Na Lu, Deborah J Wexler, J Antonio Aviña-Zubieta, Mary A De Vera, Rozalina G McCoy, Hyon K Choi
IMPORTANCE: Sodium-glucose cotransporter type 2 inhibitors (SGLT2i) are a revolutionary treatment for type 2 diabetes (T2D) with cardiovascular, kidney, and serum urate-lowering benefits. OBJECTIVE: To compare risk of incident gout and rate of recurrent flares between patients with T2D initiating SGLT2i vs sulfonylurea, most common second-line glucose-lowering therapy, when added to metformin monotherapy. DESIGN, SETTING, AND PARTICIPANTS: This sequential, propensity score-matched, new-user comparative effectiveness study using target trial emulation framework included adults with T2D receiving metformin monotherapy in a Canadian general population database from January 1, 2014, to June 30, 2022...
April 15, 2024: JAMA Internal Medicine
https://read.qxmd.com/read/38619779/factors-affecting-the-need-for-ureteral-catheterization-in-symptomatic-pregnancy-hydronephrosis
#32
JOURNAL ARTICLE
Osman Gercek, Kutay Topal, Veli Mert Yazar, Arif Demirbas
PURPOSE: In our study, considering the clinical parameters we aimed to determine the most appropriate treatment approach for symptomatic gestational hydronephrosis and conditions requiring DJS insertion. METHODS: Our study was a retrospective cross-sectional study and 137 patients were included. The patients were divided into two groups: those with conservative follow-up and those with DJS. Demographic and clinical data, the degree of HUN detected in urinary ultrasonography and the anteroposterior diameter of the renal pelvis were evaluated...
April 15, 2024: International Urology and Nephrology
https://read.qxmd.com/read/38619204/urological-complications-caused-by-inferior-vena-cava-filters-a-systematic-review
#33
JOURNAL ARTICLE
Paul J Choi, Mahmood Kabeil, Pedro J Furtado Neves, Nicos Labropoulos, Ahsan Zil-E-Ali, Faisal Aziz, Emily A Malgor, Rafael D Malgor
INTRODUCTION: Inferior vena cava (IVC) filters act in preventing pulmonary embolisms (PE). Various complications have been reported with their use. However, a credible urological complication rate, filter characteristics, and clinical presentation has yet to be summarized. Thus, we reported these complications in the form of a systematic review. EVIDENCE ACQUISITION: A search strategy was designed using PubMed, MEDLINE, and EMBASE on February 10th , 2022. The design of this search strategy did not include any language restrictions...
April 12, 2024: International Angiology: a Journal of the International Union of Angiology
https://read.qxmd.com/read/38619132/variations-in-kidney-care-management-and-access-regional-assessments-of-the-2023-international-society-of-nephrology-global-kidney-health-atlas-isn-gkha
#34
EDITORIAL
Aminu K Bello, Ikechi G Okpechi, Adeera Levin, David W Johnson
No abstract text is available yet for this article.
April 2024: Kidney International Supplements
https://read.qxmd.com/read/38618923/case-based-discussion-of-the-acute-hepatic-porphyrias-updates-on-pathogenesis-diagnosis-and-management
#35
REVIEW
Manisha Balwani, Siobán Keel, Peter Meissner, Mark Sonderup, Penelope Stein, Makiko Yasuda
The acute hepatic porphyrias (AHPs) include three autosomal dominant disorders, acute intermittent porphyria, variegate porphyria  and hereditary coproporphyria, and the ultra-rare autosomal recessive 5-aminolevulinic acid dehydratase-deficient porphyria. All four are characterized by episodic acute neurovisceral attacks that can be life-threatening if left untreated. The attacks are precipitated by factors that induce hepatic 5-aminolevulinic acid synthase 1 (ALAS1), resulting in accumulation of the porphyrin precursors, 5-aminolevulinic acid and porphobilinogen, which are believed to cause neurotoxicity...
April 15, 2024: Liver International: Official Journal of the International Association for the Study of the Liver
https://read.qxmd.com/read/38618503/capacity-for-the-management-of-kidney-failure-in-the-international-society-of-nephrology-north-america-and-the-caribbean-region-report-from-the-2023-isn-global-kidney-health-atlas-isn-gkha
#36
REVIEW
Racquel Lowe-Jones, Isabelle Ethier, Lori-Ann Fisher, Michelle M Y Wong, Stephanie Thompson, Georges Nakhoul, Shaifali Sandal, Rahul Chanchlani, Sara N Davison, Anukul Ghimire, Kailash Jindal, Mohamed A Osman, Parnian Riaz, Syed Saad, Stephen M Sozio, Somkanya Tungsanga, Alexandra Cambier, Silvia Arruebo, Aminu K Bello, Fergus J Caskey, Sandrine Damster, Jo-Ann Donner, Vivekanand Jha, David W Johnson, Adeera Levin, Charu Malik, Masaomi Nangaku, Ikechi G Okpechi, Marcello Tonelli, Feng Ye, Rulan S Parekh, Shuchi Anand
The International Society of Nephrology Global Kidney Health Atlas charts the availability and capacity of kidney care globally. In the North America and the Caribbean region, the Atlas can identify opportunities for kidney care improvement, particularly in Caribbean countries where structures for systematic data collection are lacking. In this third iteration, respondents from 12 of 18 countries from the region reported a 2-fold higher than global median prevalence of dialysis and transplantation, and a 3-fold higher than global median prevalence of dialysis centers...
April 2024: Kidney International Supplements
https://read.qxmd.com/read/38618502/capacity-for-the-management-of-kidney-failure-in-the-international-society-of-nephrology-western-europe-region-report-from-the-2023-isn-global-kidney-health-atlas-isn-gkha
#37
REVIEW
Maria Pippias, Gaetano Alfano, Dearbhla M Kelly, Maria Jose Soler, Letizia De Chiara, Timothy O Olanrewaju, Silvia Arruebo, Aminu K Bello, Fergus J Caskey, Sandrine Damster, Jo-Ann Donner, Vivekanand Jha, David W Johnson, Adeera Levin, Charu Malik, Masaomi Nangaku, Ikechi G Okpechi, Marcello Tonelli, Feng Ye, Rosanna Coppo, Liz Lightstone
Western Europe boasts advanced health care systems, robust kidney care guidelines, and a well-established health care workforce. Despite this, significant disparities in kidney replacement therapy incidence, prevalence, and transplant access exist. This paper presents the third International Society of Nephrology Global Kidney Health Atlas's findings on kidney care availability, accessibility, affordability, and quality in 22 Western European countries, representing 99% of the region's population. The known chronic kidney disease (CKD) prevalence across Western Europe averages 10...
April 2024: Kidney International Supplements
https://read.qxmd.com/read/38618501/capacity-for-the-management-of-kidney-failure-in-the-international-society-of-nephrology-north-and-east-asia-region-report-from-the-2023-isn-global-kidney-health-atlas-isn-gkha
#38
REVIEW
Winston Wing-Shing Fung, Hyeong Cheon Park, Yosuke Hirakawa, Silvia Arruebo, Aminu K Bello, Fergus J Caskey, Sandrine Damster, Jo-Ann Donner, Vivekanand Jha, David W Johnson, Adeera Levin, Charu Malik, Masaomi Nangaku, Ikechi G Okpechi, Marcello Tonelli, Seiji Ueda, Feng Ye, Yusuke Suzuki, Angela Yee-Moon Wang
Globally, there remain significant disparities in the capacity and quality of kidney care, as evidenced by the third edition of the International Society of Nephrology Global Kidney Health Atlas (ISN-GKHA). In the ISN North and East Asia region, the chronic kidney disease (CKD) burden varied widely; Taiwan had the heaviest burden of treated kidney failure (3679 per million population [pmp]) followed by Japan and South Korea. Except in Hong Kong, hemodialysis (HD) was the main dialysis modality for all other countries in the region and was much higher than the global median prevalence...
April 2024: Kidney International Supplements
https://read.qxmd.com/read/38618500/capacity-for-the-management-of-kidney-failure-in-the-international-society-of-nephrology-latin-america-region-report-from-the-2023-isn-global-kidney-health-atlas-isn-gkha
#39
REVIEW
Viviane Calice-Silva, Javier A Neyra, Alejandro Ferreiro Fuentes, Krissia Kamile Singer Wallbach Massai, Silvia Arruebo, Aminu K Bello, Fergus J Caskey, Sandrine Damster, Jo-Ann Donner, Vivekanand Jha, David W Johnson, Adeera Levin, Charu Malik, Masaomi Nangaku, Ikechi G Okpechi, Marcello Tonelli, Feng Ye, Magdalena Madero, Carmen Tzanno Martins
Successful management of chronic kidney disease (CKD) in Latin America (LA) continues to represent a challenge due to high disease burden and geographic disparities and difficulties in terms of capacity, accessibility, equity, and quality of kidney failure care. Although LA has experienced significant social and economic progress over the past decades, there are still important inequities in health care access. Through this third iteration of the International Society of Nephrology Global Kidney Health Atlas, the indicators regarding kidney failure care in LA are updated...
April 2024: Kidney International Supplements
https://read.qxmd.com/read/38618499/capacity-for-the-management-of-kidney-failure-in-the-international-society-of-nephrology-eastern-and-central-europe-region-report-from-the-2023-isn-global-kidney-health-atlas-isn-gkha
#40
REVIEW
Caner Alparslan, Jolanta Malyszko, Fergus J Caskey, Mirna Aleckovic-Halilovic, Zdenka Hrušková, Silvia Arruebo, Aminu K Bello, Sandrine Damster, Jo-Ann Donner, Vivekanand Jha, David W Johnson, Adeera Levin, Charu Malik, Masaomi Nangaku, Ikechi G Okpechi, Marcello Tonelli, Feng Ye, Vladimir Tesar, Sanjin Racki
Delivery of care for kidney failure (KF) globally has a significant disparity; even in some countries, it means end of life for the person. The International Society of Nephrology Global Kidney Health Atlas (ISN-GKHA) tries to address gaps in KF care and standardize global nephrology care. From the third iteration of the ISN-GKHA, we present data for countries in the ISN Eastern and Central Europe region. The median prevalences of chronic kidney disease (12.8%) and treated KF (873.5 pmp) were higher than the global rates, respectively...
April 2024: Kidney International Supplements
keyword
keyword
80772
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.